Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Barrigel® to Increase Distance Between the Rectum and Prostate Bed to Decrease Rectal Dose in Patients Receiving Moderately Hypofractionated Radiation Therapy Who Have Had Recurrence of Prostate Cancer After Prostatectomy

NCT06496256 is registered in ClinicalTrials.gov with Palette Life Sciences, Inc. as lead sponsor.

NCT NCT06496256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06496256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Barrigel® to Increase Distance Between the Rectum and Prostate Bed to Decrease Rectal Dose in Patients Receiving Moderately Hypofractionated Radiation Therapy Who Have Had Recurrence of Prostate Cancer After Prostatectomy
Lead sponsor
Palette Life Sciences, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2024
Completion date
December 31, 2028
Enrollment
84 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer